Virus isolation of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) for diagnostic and research purposes.

Stelzer-Braid, S; Walker, GJ; Aggarwal, A; Isaacs, SR; Yeang, M; Naing, Z; Ospina Stella, A; Turville, SG; Rawlinson, WD

Virus isolation of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) for diagnostic and research purposes.

Stelzer-Braid, S

Walker, GJ Aggarwal, A Isaacs, SR Yeang, M Naing, Z Ospina Stella, A Turville, SG Rawlinson, WD

Permalink

Publisher:: Elsevier BV
Publication Type:: Journal Article
Citation:: Pathology, 2020, 52, (7), pp. 760-763
Issue Date:: 2020-12

Closed Access

	Filename	Description	Size
	Virus isolation of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) for diagnostic and research purposes.pdf	Published Version	258.62 kB	Adobe PDF	View/Open

Copyright Clearance Process

Recently Added
In Progress
Closed Access

This item is closed access and not available.

Full metadata record

Field	Value	Language
dc.contributor.author	Stelzer-Braid, S https://orcid.org/0000-0001-6037-9305
dc.contributor.author	Walker, GJ
dc.contributor.author	Aggarwal, A
dc.contributor.author	Isaacs, SR
dc.contributor.author	Yeang, M
dc.contributor.author	Naing, Z
dc.contributor.author	Ospina Stella, A
dc.contributor.author	Turville, SG
dc.contributor.author	Rawlinson, WD
dc.date.accessioned	2020-12-15T05:21:27Z
dc.date.available	2020-09-30
dc.date.available	2020-12-15T05:21:27Z
dc.date.issued	2020-12
dc.identifier.citation	Pathology, 2020, 52, (7), pp. 760-763
dc.identifier.issn	0031-3025
dc.identifier.issn	1465-3931
dc.identifier.uri	http://hdl.handle.net/10453/144715
dc.description.abstract	Isolation of the new pandemic virus severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is essential for diagnostic and research purposes including assessment of novel therapeutics. Several primary and continuous cell lines are currently used, and new organoid and engineered cell lines are being developed for improved investigation and understanding of the human immune response to this virus. Here we review the growth of SARS-CoV-2 in reference standard cell lines, engineered cell lines and new developments in this field.
dc.format	Print-Electronic
dc.language	eng
dc.publisher	Elsevier BV
dc.relation.ispartof	Pathology
dc.relation.isbasedon	10.1016/j.pathol.2020.09.012
dc.rights	info:eu-repo/semantics/restrictedAccess
dc.subject	1103 Clinical Sciences
dc.subject.classification	Pathology
dc.title	Virus isolation of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) for diagnostic and research purposes.
dc.type	Journal Article
utslib.citation.volume	52
utslib.location.activity	England
utslib.for	1103 Clinical Sciences
pubs.organisational-group	/University of Technology Sydney/Faculty of Science
pubs.organisational-group	/University of Technology Sydney/Faculty of Science/School of Life Sciences
pubs.organisational-group	/University of Technology Sydney
utslib.copyright.status	closed_access	*
pubs.consider-herdc	false
dc.date.updated	2020-12-15T05:21:21Z
pubs.issue	7
pubs.publication-status	Published
pubs.volume	52
utslib.citation.issue	7

Abstract:

Isolation of the new pandemic virus severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is essential for diagnostic and research purposes including assessment of novel therapeutics. Several primary and continuous cell lines are currently used, and new organoid and engineered cell lines are being developed for improved investigation and understanding of the human immune response to this virus. Here we review the growth of SARS-CoV-2 in reference standard cell lines, engineered cell lines and new developments in this field.

Please use this identifier to cite or link to this item:

http://hdl.handle.net/10453/144715